Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Indrayani Biotech Ltd

INDRANIB
BSE
11.92
0.42%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Indrayani Biotech Ltd

INDRANIB
BSE
11.92
0.42%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
93Cr
Close
Close Price
11.92
Industry
Industry
Diversified
PE
Price To Earnings
PS
Price To Sales
0.62
Revenue
Revenue
151Cr
Rev Gr TTM
Revenue Growth TTM
21.44%
PAT Gr TTM
PAT Growth TTM
-202.66%
Peer Comparison
How does INDRANIB stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
INDRANIB
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
494240394432311751293635
Growth YoY
Revenue Growth YoY%
185.565.1-3.8-15.0-9.9-25.5-23.8-55.713.9-7.716.7102.1
Expenses
ExpensesCr
464033363426231453303432
Operating Profit
Operating ProfitCr
337310673-3-123
OPM
OPM%
6.46.018.18.822.919.023.816.9-5.7-1.86.87.9
Other Income
Other IncomeCr
200010003121
Interest Expense
Interest ExpenseCr
22116111-2222
Depreciation
DepreciationCr
1111143110111
PBT
PBTCr
20615110-8010
Tax
TaxCr
000000000000
PAT
PATCr
10615110-9010
Growth YoY
PAT Growth YoY%
-10.6-125.15.3-68.6228.5288.9-78.0-67.6-280.3-81.2-25.4-65.7
NPM
NPM%
2.9-1.113.72.810.72.74.02.0-16.90.62.50.3
EPS
EPS
0.3-0.11.00.20.60.10.10.1-1.60.00.10.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
3958502162163166130151
Growth
Revenue Growth%
47.7-57.7192.0164.62.0-21.715.7
Expenses
ExpensesCr
3958472655146143124149
Operating Profit
Operating ProfitCr
103-57172362
OPM
OPM%
1.80.75.6-23.511.010.614.14.81.2
Other Income
Other IncomeCr
000-404136
Interest Expense
Interest ExpenseCr
00122610125
Depreciation
DepreciationCr
0010134313
PBT
PBTCr
001-1141211-6-7
Tax
TaxCr
000000100
PAT
PATCr
001-1141210-6-7
Growth
PAT Growth%
-39.9-1,489.0139.6168.7-12.6-158.6-20.2
NPM
NPM%
-0.1-0.11.6-53.27.27.36.3-4.7-4.9
EPS
EPS
0.00.00.3-6.01.42.81.5-0.4-1.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
444343434464646
Reserves
ReservesCr
00-3-15-1010182330
Current Liabilities
Current LiabilitiesCr
69141219728710270
Non Current Liabilities
Non Current LiabilitiesCr
00787367165101
Total Liabilities
Total LiabilitiesCr
1012514051156234268274
Current Assets
Current AssetsCr
471991978145178184
Non Current Assets
Non Current AssetsCr
6632313278899091
Total Assets
Total AssetsCr
1012514051156234268274

Cash Flow

Consolidated
Standalone
Financial YearMar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
1260416-30-7
Investing Cash Flow
Investing Cash FlowCr
-30-4-1-1-47-1625
Financing Cash Flow
Financing Cash FlowCr
2-1-10-33344-18
Net Cash Flow
Net Cash FlowCr
011-112-20
Free Cash Flow
Free Cash FlowCr
-22303-5-47-8
CFO To PAT
CFO To PAT%
-1,879.2-2,578.4738.0-2.392.6135.7-291.2110.4
CFO To EBITDA
CFO To EBITDA%
126.0389.4214.7-5.260.794.0-129.5-107.7

Ratios

Consolidated
Standalone
Financial YearMar 2011Mar 2012Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
0032210419322465
Price To Earnings
Price To Earnings
0.00.03.80.023.522.235.10.0
Price To Sales
Price To Sales
0.00.00.11.01.71.21.40.5
Price To Book
Price To Book
0.00.011.91.14.34.43.50.9
EV To EBITDA
EV To EBITDA
2.81.55.5-7.418.015.114.332.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
100.0100.034.925.233.337.341.636.4
OPM
OPM%
1.80.75.6-23.511.010.614.14.8
NPM
NPM%
-0.1-0.11.6-53.27.27.36.3-4.7
ROCE
ROCE%
7.26.414.0-26.214.715.611.92.9
ROE
ROE%
-1.3-1.9318.3-56.918.426.916.5-8.8
ROA
ROA%
-0.5-0.51.6-28.08.67.74.5-2.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **1. Company Overview** **Indrayani Biotech Limited (IBL)** is a diversified Indian conglomerate operating across multiple high-growth sectors including **Food & Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture, and Infrastructure**. Originally focused on biotechnology, IBL has strategically transformed into a multi-sector holding company through the **aggregation of high-potential MSMEs**, integrating them into a unified corporate ecosystem while preserving their entrepreneurial leadership. The company follows a **"brownfield aggregation" model**, acquiring established, independently managed MSMEs and providing them with financial, operational, compliance, and strategic support, enabling rapid scalability and enhanced value realization. IBL ensures **aligned growth** by allowing original promoters to retain management control while adding board oversight from the listed parent entity. --- ### **2. Business Model & Strategy** - **MSME Aggregation Strategy**: Since 2021, IBL has systematically aggregated successful MSMEs across sectors, starting with Helios Solutions (2018), A-Diet Express (2018), and Nandhini Biotech (2020). The goal is to unlock latent potential through **capital infusion, shared services, and operational synergy**, with future monetization pathways via SME exchanges. - **Inclusive & Win-Win Structure**: Subsidiaries retain promoter ownership and leadership. IBL provides corporate governance, compliance, access to capital, and centralized functions, ensuring stability and scalability. - **Centralized Ecosystem Support**: - Shared infrastructure in **Finance, HR, Legal, IT, and Secretarial services** reduces overheads. - Encourages **knowledge sharing, technology repurposing, and cross-functional collaboration**. - Subsidiaries can **procure raw materials and sell outputs within the group**, boosting internal demand and value realization. - **Growth through Inorganic Expansion**: IBL actively pursues **acquisitions and strategic partnerships**, particularly in the healthcare, dairy, and power electronics sectors. --- ### **3. Key Subsidiaries & Business Verticals** #### **A. Healthcare & Pharma – IBL Healthcare Limited** - **Established**: October 2020; fully acquired by IBL in March 2022. - **Focus**: Integrated healthcare solutions via **single-specialty clinics, hospital partnerships, pharma marketing, manufacturing, and medical equipment**. - **Acquisitions**: - **Healthway India Pvt Ltd** (pharma marketing). - **Kniss Laboratories Pvt Ltd** (GMP-certified pharma manufacturing, ISO 9001). - **Peekay Mediequip** (manufacturer of needles, syringes, IV sets). - **Vaasan Medical Center** (pharmacy retail chain). - **Clinical Services**: - IBL Eyecare Clinic (Tiruvannamalai). - Nalam Multispeciality Dental Hospital (Chennai). - LA FUSE Hair & Skin Clinic (Chennai). - **Strategy**: Hub-and-spoke model with urban hospitals acting as hubs and OP clinics as feeders. Plans to expand service offerings nationwide. - **R&D & Marketing**: - Launching branded **allopathic, Ayurvedic, and nutraceutical products** under 'Healthway'. - Proprietary developments include CELNORM (onco-nutrition), ARLIN (arthritis), Loparet (GI health), and HERCOF (herbal cough syrup). - **Export Ambitions**: Products exported to East Europe, Middle East, and Southeast Asia; scaling up international footprint. #### **B. Food & Hospitality – A-Diet Express Hospitality Service** - **Established**: 2002; merged with IBL in April 2018. - **Services**: Contract catering for **corporate offices, IT parks, hospitals, educational institutions**, and **food courts under 'Nalla Sappadu'**. - **Scale**: - Operates across **12 states, 20+ cities**, serving **over 100,000 meals daily**. - Two central kitchens (combined 50,000 meals/day), multiple onsite kitchens. - Clients include **IIT Roorkee (₹12 Cr contract), Gautam Buddha University (₹8 Cr)**. - **Facilities**: - New **central kitchen in Poonamallee (Chennai)**, equipped with **touch-free, energy-efficient technology**. - ISO 9001 & ISO 22000 certified. - **Market Opportunity**: Part of India’s ₹6.6 lakh crore food services sector (10–11% CAGR), with strong momentum in institutional catering. #### **C. Dairy – Dindigul Farm Products Pvt Ltd & A.R. Dairy** - **Brands**: *EnNutrica* (dairy proteins), *Raaj Milk*, *Malabar*. - **Facilities**: - 19-acre plant in Dindigul; 17-acre facility. - Combined processing capacity: **300,000 liters/day**. - Produces **milk protein concentrate, casein, whey powder, SMP, WMP, dairy whiteners, curd, ghee**. - **Capacity**: 60 tons/month of protein-based products; turnover of **₹200+ crores annually**. - **Sustainability**: ~80–100% renewable energy use. - **Direct Sourcing**: Expanding procurement directly from farmers via digital payments to improve margins and farmer engagement. - **Market Outlook**: Indian dairy protein market valued at **₹5,500 Cr (2023)**, growing at **10% CAGR**; high export demand for casein and protein concentrates. #### **D. Engineering** 1. **Matrix Boilers Private Limited** - **Established**: 2006; acquired/revived by IBL. - **Product Range**: Industrial boilers (2–50 TPH), waste heat recovery, economizers, pressure vessels. - **Technology**: Holds a **patented HYBRID boiler design** that reduces fuel/power consumption by 15–20%. - **Global Footprint**: Over 450 boilers supplied in **India, Sri Lanka, Myanmar, Bangladesh, Africa**. - **Key Projects**: Empaneled as supplier of boiler shells for **Southern Railway’s T Engine steam locomotive project**. - **Facility**: Two units on 4-acre land in Mathur, Tiruchirappalli. 2. **Helios Solutions Limited** (now merged with IBL) - **Founded**: 1995; merged in 2018. - **Core Business**: Design, manufacturing, and service of **industrial UPS systems, battery chargers, inverters, voltage stabilizers, and special-purpose machines**. - **Defense & Space Clients**: - Supplied **2x25 kW modular power systems for Indian Navy submarines**. - Provided **pyro control consoles for ISRO/DRDO satellite launch facilities**. - Critical power systems for **Chennai Port Trust, ISRO, Indian Navy, DRDO**. - **Innovations**: - Developed India’s first **Automatic Rescue Device for elevators (ARD)** – over **15,000 units installed**. - Piloted **50 electric garbage collection vehicles (ePIC)** for Chennai Corporation with **1-year successful operation**. - **Global Presence**: Installations in **Spain, South Africa, UAE, Thailand, Italy**. - **Partnerships**: 20+ year alliances with **Gammatronic (Israel)** and **Gewiss (Italy)**. #### **E. Biotechnology & Agri** - **Core Activities**: - Manufactures **biofertilizers** (Pseudomonas, Trichoderma viride), **biopesticides**, **vermicompost**, **neem-based products**, **VAM**. - Offers **turnkey consultancy** in agriculture, aquaculture, horticulture, tissue culture, soil/water testing, and nursery development. - **R&D & Facilities**: - Advanced labs in **Ponneri (Chennai)** and **Sirumugai (Coimbatore)**. - New **2-acre biotech plant** in Sirumugai for bio-fortified vermicompost and coir pith. - **Integration**: - Supplies inputs to **HSL Agri Solutions’ 100-acre organic farm**. - Products used in internal dairy and food production; also sold commercially. - **Brand Integration**: Merger with **Nandhini Biotech (2020)** accelerated product portfolio and market reach. #### **F. Agriculture & Agro-Processing – HSL Agri Solutions** - **Land**: ~100 acres (owned & leased). - **Functions**: - Backward integration for **A-Diet**; forward integration with **Biotech**. - Cultivates **organic vegetables, fruits, groceries** using bio-inputs, as per A-Diet demand forecasts. - Sources & procures bulk groceries; trades surplus stock. - **Milestone Acquisition**: Acquired **Dilasa Agro Processors Pvt Ltd (2024)**, an agro-processing unit in Aurangabad. - **Operations**: 2-acre facility processing dal (tur, channa), tomato ketchup/puree, mango pulp, bakery items (Nutri Bakes), and cattle feed. - **Brands**: Baliraja, Mr. Tom, Tasty Tom, Aamra. - **Farmer Integration**: Uses **Farmer Producer Organizations (FPOs)** to eliminate middlemen. #### **G. Infrastructure – HSLPrime Properties Pvt Ltd** - **Founded**: 2017; real estate and infrastructure arm. - **Projects**: - **Desavani Towers**: 44,000 sq ft Class A commercial building in **Guindy, Chennai**. - Pipeline: More commercial, residential, and **DTCP-approved plots (up to 50 acres)**. - **Concept Developments**: - Farm lands with **"Work from Farm"** models for IT professionals and HNIs. - Green housing for retirees, supported by **agro division for centralized farm management**. - **Collaborative Model**: Integrates with Agro division for sustainable land use and value creation. #### **H. Finance & CSR** - **IBL Investments**: Provides financial support and working capital funding to subsidiaries. - **IBL Social Foundation**: Handles corporate social responsibility initiatives. --- ### **6. Key Dates & Milestones Summary** | Year | Milestone | |------|-----------| | **2018** | Merger with Helios Solutions and A-Diet Express Hospitality. | | **2020** | Launch of IBL Healthcare; integration of Nandhini Biotech. | | **2021–2023** | Aggregation strategy launched; multiple acquisitions in pharma, agro, and real estate. | | **2022–2024** | Kniss Laboratories, Healthway India, Dilasa Agro acquired. IBL Dairy listed on BSE SME. | | **2024–2025** | Expansion of central kitchens, hospital partnerships, ePIC vehicles, solar projects. Desavani Towers under construction. | | **Sep 2025** | Strengthening of group ecosystem, centralized governance, and focus on scalable MSME integration. |